; and (F) comorbidities, vaccination status, and demographics, including age, gender, race and ethnicity, geographic location, disability, and occupation of registry participants; (2) synthesis of information relating to individuals experiencing Long COVID and related conditions and other information available through the patient registry; (3) dissemination of information to relevant Federal departments and agencies and patients participating in the registry to inform treatment and policy related to COVID–19, Long COVID, and related conditions; (4) an assurance that the registry utilizes common data elements and definitions for use in order to promote appropriate data sharing for ongoing and future research; and (5) outreach to, and inclusion in the patient registry, as appropriate, of individuals, including children and older adults, from communities impacted by high COVID–19 and Long COVID rates, communities affected by health disparities and inequities (including Indian Tribes and Tribal organizations, urban Indian organizations, and people with disabilities), individuals with related conditions, health care providers, first responders, military service members, veterans, pregnant and lactating women, frontline workers who may be impacted by high COVID–19 and Long COVID rates, and health care providers from diverse disciplines that may treat individuals with COVID–19, Long COVID, and related conditions. (c) Voluntary participation